Literature DB >> 2657347

The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.

N Stingemore1, G R Francis, M Toohey, D B McGechie.   

Abstract

Erythromycin resistance in Streptococcus pyogenes is unusual except in Japan. Since January 1, 1985, a dramatic increase has occurred in the prevalence of erythromycin-resistant Strept. pyogenes infections in the outpatients who have presented to Fremantle Hospital, Western Australia. In 1985, 1% of isolates of Strept. pyogenes was erythromycin-resistant. This had risen to 9.1% of isolates in 1986 and to 17.6% of isolates in 1987. Several M- and T-types of Strept. pyogenes were involved. Treatment failure now can be expected when erythromycin is prescribed for the treatment of common infections in outpatients at this hospital. Laboratories that use disc methods of antimicrobial susceptibility testing may not detect erythromycin resistance in these organisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657347     DOI: 10.5694/j.1326-5377.1989.tb136725.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  20 in total

1.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Different erythromycin resistance mechanisms in group C and group G streptococci.

Authors:  J Kataja; H Seppälä; M Skurnik; H Sarkkinen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 3.  What can be done about resistance to antibiotics?

Authors:  J Turnidge
Journal:  BMJ       Date:  1998-09-05

4.  The frequency of resistance to erythromycin in group A streptococci in Ankara.

Authors:  A E Kürekçi; M Baysallar; A Karaarslan; G Emekdaş; V Köseoğlu; R Akin; O Ozcan
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

Review 5.  Reconsidering sore throats. Part I: Problems with current clinical practice.

Authors:  W J McIsaac; V Goel; P M Slaughter; G W Parsons; K V Woolnough; P T Weir; J R Ennet
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 6.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

7.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

Authors:  E Perez-Trallero; M Urbieta; M Montes; I Ayestaran; J M Marimon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

9.  Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

Authors:  C García-Rey; L Aguilar; F Baquero; J Casal; J E Martín
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.